Search results
Results from the WOW.Com Content Network
The Intellectual Property Office of Singapore (IPOS) is a statutory board under the Ministry of Law of the Government of Singapore.IPOS advises on and administers intellectual property (IP) laws, promotes IP awareness, and provides the infrastructure to facilitate the development of IP in Singapore.
A patent office is a governmental or intergovernmental organization which controls the issue of patents. In other words, "patent offices are government bodies that may grant a patent or reject the patent application based on whether the application fulfils the requirements for patentability ."
On 30 December 2020, Singapore became the first country in Asia to start its COVID-19 vaccination campaign. The vaccine is free for all Singaporeans and long-term residents. Health workers, other frontline workers and seniors were the first inoculated with the vaccine jointly developed by BioNTech and Pfizer. [17]
The high number of patent families for Spain in the 1800s is related to the superior preservation and cataloguing of the data by Spanish Patent and Trademark Office compared to other countries (see 1836 U.S. Patent Office fire). The US was the World's leader in terms of patent families filed between 1900 and 1966, when Japan took over.
Hilleman Laboratories has recently announced a significant advancement in improving access to the lifesaving rotavirus vaccine for children. The vaccine candidate will have optimized bulk antigen production processes combined with simple yet robust formulation and a scalable fill/finish to ensure a competitively priced vaccine which will improve access in the low-resource settings like India.
The Spanish Patent and Trademark Office (Spanish: Oficina Española de Patentes y Marcas, sometimes abbreviated SPTO or OEPM) is an autonomous agency of the Ministry of Industry, Trade and Tourism of Spain. [1] The Spanish Patent and Trademark Office, created in the 19th century, is in charge of patents in Spain.
In April 2022, a Singapore study by infectious diseases experts from the National Centre for Infectious Diseases and the Ministry of Health found that CoronaVac recipients were 4.59 times more likely to have severe COVID-19 as well as 2.37 times more likely to be infected, compared to those who took the Pfizer-BioNTech vaccine. [61] [62]
In contrast to research and development, the vaccine production market, even for out-of-patent vaccines, is highly concentrated. 80% of global production is in the hand of five large companies, which hold key patents. [6] [7] This reduces competition and allows high, uncompetitive prices, often more than 100 times the cost of production. [8] [9]